Wistar Institute Researchers Discover New Combination Therapy Approach for Metastatic Ovarian Cancer
21. November 2024 12:10 ET
|
The Wistar Institute
PHILADELPHIA, PA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- PHILADELPHIA — (November 21, 2024) — The Wistar Institute’s Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center’s...
The Wistar Institute and University of Pennsylvania Scientists Identify Potential Target Gene within Certain HIV Reservoir Cells
03. Oktober 2024 15:08 ET
|
The Wistar Institute
Philadelphia, PA, Oct. 03, 2024 (GLOBE NEWSWIRE) -- New findings could lead to different research tactics for scientists investigating a cure for HIV. Results from The Wistar Institute’s Lieberman...
Wistar Institute Researchers Identify Parkinson-related Protein’s Role in Cancer and T Cell Activation
17. September 2024 12:54 ET
|
The Wistar Institute
PHILADELPHIA, PA, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The Wistar Institute’s President and CEO, Dario C. Altieri, M.D., and team have demonstrated the role of Parkin — a protein implicated in...
The Wistar Institute Launches HIV Cure and Viral Diseases Center
17. Juli 2024 14:02 ET
|
The Wistar Institute
PHILADELPHIA, PA, July 17, 2024 (GLOBE NEWSWIRE) -- The Wistar Institute — building on its history of leading advances in human health as the nation’s first nonprofit biomedical research institute —...
Wistar Scientists Develop Novel Antibody Treatment for Kidney Cancer
04. Juni 2024 10:50 ET
|
The Wistar Institute
PHILADELPHIA, PA, June 04, 2024 (GLOBE NEWSWIRE) -- Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only...
Wistar Research Identifies Mechanisms for Selective Multiple Sclerosis Treatment Strategy
28. Mai 2024 11:30 ET
|
The Wistar Institute
PHILADELPHIA, PA, May 28, 2024 (GLOBE NEWSWIRE) -- PHILADELPHIA — (May 28, 2024) — The Wistar Institute’s Paul M. Lieberman, Ph.D., and lab team led by senior staff scientist and first author,...
The Wistar Institute Awarded Second National Science Foundation Grant to Expand Award-winning STEM Training Program
14. Mai 2024 12:32 ET
|
The Wistar Institute
PHILADELPHIA, PA, May 14, 2024 (GLOBE NEWSWIRE) -- PHILADELPHIA — (May 14, 2024) — The Wistar Institute was awarded a $649,971 grant from the National Science Foundation (NSF) to support the...
Wistar Scientists Discover New Immunosuppressive Mechanism in Brain Cancer
03. Mai 2024 11:32 ET
|
The Wistar Institute
PHILADELPHIA, PA, May 03, 2024 (GLOBE NEWSWIRE) -- The Wistar Institute assistant professor Filippo Veglia, Ph.D., and team, have discovered a key mechanism of how glioblastoma — a serious and often...
Promising Personalized Approach to Liver Cancer Therapy Made Possible by DNA-based Neoantigen Research Designed at The Wistar Institute
30. April 2024 10:18 ET
|
The Wistar Institute
PHILADELPHIA, PA, April 30, 2024 (GLOBE NEWSWIRE) -- Hepatocellular carcinoma (HCC), or liver cancer, is an aggressive malignancy with limited treatment options. An immunologically cold cancer —...
Wistar Scientists Identify Pro-aging ‘Sugar Signature’ in the Blood of People Living with HIV
10. April 2024 05:05 ET
|
The Wistar Institute
PHILADELPHIA, PA, April 10, 2024 (GLOBE NEWSWIRE) -- The Wistar Institute’s associate professor Mohamed Abdel-Mohsen, Ph.D., along with his team and collaborators, has identified sugar abnormalities...